Search Within

ENCEPHALOMYELITIS

Astragaloside IV Supplementation Promotes A Neuroprotective Effect in Experimental Models of Neurological Disorders: A Systematic Review

Journal: Current Neuropharmacology
Volume: 17, Issue: 7
Page: 648-665
Authors: Ianara M. Costa, Francisca O.V. Lima, Luciana C.B. Fernandes, Bianca Norrara, Francisca I. Neta, Rodrigo D. Alves, José R.L.P. Cavalcanti, Eudes E.S. Lucena, Jeferson S. Cavalcante, Amalia C.M. Rego, Irami A. Filho, Dinalva B. Queiroz, Marco A.M. Freire and Fausto P. Guzen*

The Effects of D-aspartate on Neurosteroids, Neurosteroid Receptors, and Inflammatory Mediators in Experimental Autoimmune Encephalomyelitis

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 19, Issue: 3
Page: 316-325
Authors: Mahdi Goudarzvand, Yaser Panahi, Reza Yazdani, Hosein Miladi, Saeed Tahmasebi, Amin Sherafat, Sanaz Afraei, Kosar Abouhamzeh, Mahnaz Jamee, Kawthar Jasim Mohammad Rida Al-Hussieni, Hamed Mohammadi, Ali Mohebbi, Nikoo Hossein-Khannazer, Majid Zaki-Dizaji, Maria Maddalena Di Fiore, Antimo D'Aniello and Gholamreza Azizi*

Tetramethoxyluteolin for the Treatment of Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 18, Issue: 21
Page: 1872-1882
Authors: Theoharis C. Theoharides* and Irene Tsilioni

MiR-19b Functions as a Potential Protector in Experimental Autoimmune Encephalomyelitis

Journal: Current Molecular Medicine
Volume: 18, Issue: 5
Page: 312-321
Authors: B. Hu, Z.L. Hu, Q.M. Zeng, B. Xiao and H. Yang*

Mechanism by which Regulatory Rheumatoid Factor Prevents Experimental Autoimmune Encephalomyelitis

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 18, Issue: 6
Page: 596-601
Authors: Elena Stolyarova*, Liubov Beduleva, Igor Menshikov, Alexandr Snigiryev and Tatyana Khramova

A Review on Possible Therapeutic Effect of Nigella sativa and Thymoquinone in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17, Issue: 6
Page: 412-420
Authors: Saeed Samarghandian, Tahereh Farkhondeh* and Fariborz Samini

Experimental Autoimmune Encephalomyelitis (EAE) Model of Cynomolgus Macaques Induced by Recombinant Human MOG1-125 (rhMOG1-125) Protein and MOG34-56 Peptide

Journal: Protein & Peptide Letters
Volume: 24, Issue: 12
Page: 1166-1178
Authors: Zhen Peng, Libiao Zhang, Huaqian Wang, Xiangyang He, Xingwen Peng, Qin Zhang, Hui Liu, Junhua Rao, Haifeng Wang, Jie Wu* and Yunxiao Sun*

Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions

Journal: Medicinal Chemistry
Volume: 14, Issue: 2
Page: 106-119
Authors: Samuel S. Duffy, Justin G. Lees, Chamini J. Perera and Gila Moalem-Taylor*

An Update on the Role of Matrix Metalloproteinases in the Pathogenesis of Multiple Sclerosis

Journal: Medicinal Chemistry
Volume: 14, Issue: 2
Page: 155-169
Authors: Marina Boziki and Nikolaos Grigoriadis*

Basic Approaches in Therapy of Multiple Sclerosis (MS) and Related Diseases: Current Achievement and Prospective

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 18, Issue: 1
Page: 21-31
Authors: Dusanka S. Skundric*

Sphingosine-1-Phosphate Receptors in the Central Nervous and Immune Systems

Journal: Current Drug Targets
Volume: 17, Issue: 16
Page: 1841-1850
Authors: Luke M. Healy and Jack P. Antel

GABAergic Agonists Modulate the Glutamate Release from Frontal Cortex Synaptosomes of Rats with Experimental Autoimmune Encephalomyelitis

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 14, Issue: 2
Page: 105-110
Authors: Nicolás Fernández Hurst, Natalí L. Chanaday and German A. Roth

Angiopoietin-1 and C16 Peptide Attenuate Vascular and Inflammatory Responses in Experimental Allergic Encephalomyelitis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15, Issue: 4
Page: 496-513
Authors: Beibei Wang, Ke-wei Tian, Fan Zhang, Hong Jiang and Shu Han

Therapeutic Impact of Sphingosine 1-phosphate Receptor Signaling in Multiple Sclerosis

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16, Issue: 7
Page: 547-554
Authors: Kristina Candido, Henry Soufi, Mausumi Bandyopadhyay and Subhajit Dasgupta

Scope and Applications of Nanomedicines for the Management of Multiple Sclerosis

Journal: Current Drug Metabolism
Volume: 16, Issue: 8
Page: 602-608
Authors: Mahmood Rasool, Arif Malik, Abdul Manan, Shakeel Ahmed Ansari, Muhammad Asif, Mahmood Husain Qazi, Mohammad Amjad Kamal and Peter Natesan Pushparaj

Myalgic Encephalomyelitis: Symptoms and Biomarkers

Journal: Current Neuropharmacology
Volume: 13, Issue: 5
Page: 701-734
Authors: Leonard A. Jason, Marcie L. Zinn and Mark A. Zinn

The Role of Toll-Like Receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A New Promising Therapeutic Approach?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14, Issue: 7
Page: 903-914
Authors: Maria Elsa Gambuzza, Francesca Maria Salmeri, Luca Soraci, Giulia Soraci, Vincenza Sofo, Silvia Marino and Placido Bramanti

Defining and Regulating Acute Inflammatory Lesion Formation during the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14, Issue: 7
Page: 915-935
Authors: Christopher Bolton and Paul Smith

Mouse Models of Multiple Sclerosis: Lost in Translation?

Journal: Current Pharmaceutical Design
Volume: 21, Issue: 18
Page: 2440-2452
Authors: David Baker and Sandra Amor

Heme Oxygenase-1 as a Target for the Design of Gene and Pharmaceutical Therapies for Autoimmune Diseases

Journal: Current Gene Therapy
Volume: 14, Issue: 3
Page: 218-235
Authors: Juan P. Mackern-Oberti, Sebastian A. Riquelme, Carolina Llanos, Camila B. Schmidt, Thomas Simon, Ignacio Anegon, Evelyn Jara, Claudia A. Riedel, Susan M. Bueno and Alexis M. Kalergis

Oxidative and Nitrosative Stress and Immune-inflammatory Pathways in Patients with Myalgic Encephalomyelitis (ME)/Chronic Fatigue Syndrome (CFS)

Journal: Current Neuropharmacology
Volume: 12, Issue: 2
Page: 168-185
Authors: Gerwyn Morris and Michael Maes

Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12, Issue: 8
Page: 1205-1218
Authors: Alejandro F. De Nicola, Florencia Coronel, Laura I. Garay, Gisella Gargiulo-Monachelli, Maria Claudia Gonzalez Deniselle, Susana L. Gonzalez, Florencia Labombarda, Maria Meyer, Rachida Guennoun and Michael Schumacher

Metallothionein I+II Expression as an Early Sign of Chronic Relapsing Experimental Autoimmune Encephalomyelitis in Rats

Journal: Current Aging Science
Volume: 6, Issue: 1
Page: 37-44
Authors: Hrvoje Jakovac, Marin Tota, Damir Grebic, Tanja Grubic-Kezele, Vesna Barac-Latas, Ines-Mrakovcic-Sutic, Cedomila Milin and Biserka Radosevic-Stasic

Multiple Roles of Histamine in Autoimmune Demyelinating Disease of the Central Nervous System

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 10, Issue: 6
Page: 418-426
Authors: Massimo Costanza, Silvia Musio and Rosetta Pedotti

The Ambivalent Role of Apoptosis in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 18, Issue: 29
Page: 4453-4464
Authors: Holger M. Reichardt and Fred Luhder

Targeting Vascular Changes in Lesions in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12, Issue: 1
Page: 7-14
Authors: Stephen J. Karlik, Wendi A. Roscoe, Cindy Patinote and Christiane Contino-Pepin

Viral Infection - A Cure for Type 1 Diabetes?

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 19
Page: 2048-2052
Authors: Edith Hintermann and Urs Christen

Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 1
Page: 83-94
Authors: Ciriaco A. Piccirillo and Gerald J. Prud'homme

The Importance of NAD in Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 15, Issue: 1
Page: 64-99
Authors: W. Todd Penberthy and Ikuo Tsunoda

Interleukin-25: Key Regulator of Inflammatory and Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 17, Issue: 34
Page: 3781-3785
Authors: David Saadoun, Benjamin Terrier and Patrice Cacoub

M2000, Foundation of a New Generation Among NSAIDs

Journal: Letters in Drug Design & Discovery
Volume: 2, Issue: 5
Page: 412-423
Authors: A. Mirshafiey, B. Rehm, S. Cuzzocrea, H. Matsuo, E. Mazzon, S. Nakane, C- S. Koh and S. Miyoshi

Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9, Issue: 4
Page: 315-327
Authors: Catriona T. Prendergast and Stephen M. Anderton

From Cannabis to Endocannabinoids in Multiple Sclerosis: A Paradigm of Central Nervous System Autoimmune Diseases

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 4, Issue: 6
Page: 667-675
Authors: Anna M. Malfitano, Giuseppe Matarese and Maurizio Bifulco

Hemichannels in the Neurovascular Unit and White Matter Under Normal and Inflamed Conditions

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10, Issue: 3
Page: 404-414
Authors: Juan A. Orellana, Xavier F. Figueroa, Helmuth A. Sanchez, Susana Contreras-Duarte, Victoria Velarde and Juan C. Saez

ADAMTS Proteinases: Potential Therapeutic Targets?

Journal: Current Pharmaceutical Biotechnology
Volume: 7, Issue: 1
Page: 25-31
Authors: Gavin C. Jones

Anti-Inflammatory Immunotherapy for Multiple Sclerosis/Experimental Autoimmune Encephalomyelitis (EAE) Disease

Journal: Current Medicinal Chemistry
Volume: 12, Issue: 25
Page: 2947-2962
Authors: Jagat R. Kanwar

Gene Therapy-Mediated Modulation of Immune Processes in the Central Nervous System

Journal: Current Pharmaceutical Design
Volume: 9, Issue: 24
Page: 2002-2008
Authors: Roberto Furlan, Stefano Pluchino and Gianvito Martino

The Contribution of γδ T Cells to the Pathogenesis of EAE and MS

Journal: Current Molecular Medicine
Volume: 9, Issue: 1
Page: 15-22
Authors: Sarah E. Blink and Stephen D. Miller

Involvement of IL-1R/TLR Signalling in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis

Journal: Current Molecular Medicine
Volume: 12, Issue: 3
Page: 218-236
Authors: V. Ruggiero

Complementary Peptide Epitopes and Antiidiotypic Antibodies in Autoimmunity

Journal: Protein & Peptide Letters
Volume: 11, Issue: 4
Page: 367-375
Authors: Maria Sakarellos-Daitsiotis, Manh-Thong Cung, Constantinos Sakarellos, Zouhair El Hilali, Aggeliki Kosmopoulou and Chryssa Voitharou

The Role of Osteopontin in Experimental Autoimmune Encephalomyelitis (EAE) and Multiple Sclerosis (MS)

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 9, Issue: 4
Page: 249-256
Authors: Manjit Braitch and Cris S. Constantinescu

New Approach to Immunotherapy Against Organ-specific Autoimmune Diseases with T Cell Receptor and Chemokine Receptor DNA Vaccines

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5, Issue: 1
Page: 73-77
Authors: Yoh Matsumoto

Promotion of Remyelination by Immunoglobulins: Implications for the Treatment of Multiple Sclerosis

Journal: Current Pharmaceutical Design
Volume: 12, Issue: 2
Page: 241-249
Authors: C. Trebst and M. Stangel

Experimental Models of Relapsing-Remitting Multiple Sclerosis: Current Concepts and Perspective

Journal: Current Neurovascular Research
Volume: 2, Issue: 4
Page: 349-362
Authors: D. S. Skundric

Poly(ADP-Ribose) Polymerase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 10, Issue: 4
Page: 321-340
Authors: Garry J. Southan and Csaba Szabó

Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis

Journal: Current Neuropharmacology
Volume: 7, Issue: 1
Page: 60-64
Authors: D. Moharregh-Khiabani, R. A. Linker, R. Gold and M. Stangel

Glutamate and Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 19, Issue: 9
Page: 1295-1299
Authors: M. Frigo, M. G. Cogo, M. L. Fusco, M. Gardinetti and B. Frigeni

Therapeutic Targeting of Leukocyte Trafficking Across the Blood-Brain Barrier

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 6, Issue: 4
Page: 210-222
Authors: Caroline Coisne, Ruth Lyck and Britta Engelhardt

Human Rabies Encephalitis Prevention and Treatment: Progress Since Pasteurs Discovery

Journal: Infectious Disorders - Drug Targets
Volume: 11, Issue: 3
Page: 251-299
Authors: Laurent Dacheux, Olivier Delmas and Herve Bourhy

Implication for Thiazolidinediones (TZDs) as Novel Potential Anti- Inflammatory Drugs

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4, Issue: 5
Page: 531-541
Authors: H. Xu, D. Finas, F. Koster, G. Griesinger, M. Friedrich, K. Diedrich and D. Hornung

Evaluation of the Effects of a New Drug on Brain Leukocyte Infiltration in an Experimental Model of Autoimmune Encephalomyelitis

Journal: Letters in Drug Design & Discovery
Volume: 3, Issue: 3
Page: 138-148
Authors: A. Mangas, R. Covenas, D. Bodet, M. P. Dabadie, G. Glaize and M. Geffard

Estrogen and Cytokines Production - The Possible Cause of Gender Differences in Neurological Diseases

Journal: Current Pharmaceutical Design
Volume: 11, Issue: 8
Page: 1017-1030
Authors: A. Czlonkowska, A. Ciesielska, G. Gromadzka and I. Kurkowska-Jastrzebska

The Clinical Spectrum, Diagnosis, Pathogenesis and Treatment of Hashimotos Encephalopathy (Recurrent Acute Disseminated Encephalomyelitis)

Journal: Current Medicinal Chemistry
Volume: 10, Issue: 19
Page: 1945-1953
Authors: Abhijit Chaudhuri and Peter O. Behan

A New Drug Candidate (GEMSP) for Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 16, Issue: 25
Page: 3203-3214
Authors: Arturo Mangas, Rafael Covenas, Dominique Bodet, Sebastien Duleu and Michel Geffard

Bridged Piperazines and Piperidines as CCR1 Antagonists with Oral Activity in Models of Arthritis and Multiple Sclerosis

Journal: Letters in Drug Design & Discovery
Volume: 3, Issue: 10
Page: 689-694
Authors: Laszlo Revesz, Birgit Bollbuck, Thomas Buhl, Janet Dawson, Roland Feifel, Richard Heng, Peter Hiestand, Helmut Sparrer, Achim Schlapbach, Rudolf Waelchli and Pius Loetscher

A Rational Approach on the Use of Sex Steroids in Multiple Sclerosis

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 3, Issue: 1
Page: 34-39
Authors: Martocchia Antonio, Frugoni Patrizia, Indiano Ilaria and Falaschi Paolo

GPR30 Forms an Integral Part of E2-Protective Pathway in Experimental Autoimmune Encephalomyelitis

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Volume: 11, Issue: 4
Page: 262-274
Authors: Sheetal Bodhankar and Halina Offner

Chemokines and Chemokine Receptors: Potential Therapeutic Targets in Multiple Sclerosis

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3, Issue: 3
Page: 279-290
Authors: Diane M. Muller, Michael P. Pender and Judith M. Greer

Round and Round we Go: Cyclic Peptides in Disease

Journal: Current Medicinal Chemistry
Volume: 13, Issue: 19
Page: 2221-2232
Authors: John Matsoukas, Vasso Apostolopoulos, Eliada Lazoura, George Deraos, Minos-Timotheos Matsoukas, Maria Katsara, Theodore Tselios and Spyros Deraos

The Changing Face of Cytokines in the Brain: Perspectives From EAE

Journal: Current Pharmaceutical Design
Volume: 11, Issue: 8
Page: 1031-1037
Authors: R. D. Wheeler and T. Owens

Therapeutic Potential of Vitamin D for Multiple Sclerosis

Journal: Current Medicinal Chemistry
Volume: 15, Issue: 5
Page: 499-505
Authors: Masaaki Niino, Toshiyuki Fukazawa, Seiji Kikuchi and Hidenao Sasaki

Prostanoid Receptors as Possible Targets for Anti-Allergic Drugs: Recent Advances in Prostanoids on Allergy and Immunology

Journal: Current Drug Targets
Volume: 11, Issue: 12
Page: 1605-1613
Authors: Tetsuya Honda, Yoshiki Tokura, Yoshiki Miyachi and Kenji Kabashima

Vitamin D: Status, Supplementation and Immunomodulation

Journal: Current Nutrition & Food Science
Volume: 2, Issue: 4
Page: 315-336
Authors: Maria S. Barnes, Paula J. Robson, Maxine P. Bonham, J. J. Strain and Julie M.W. Wallace

Therapeutic Benefits of Regulating Inflammation in Autoimmunity

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 7, Issue: 3
Page: 203-210
Authors: Enayat Nikoopour, Jordan Ari Schwartz and Bhagirath Singh

Therapeutic Potential of Glycolipid Ligands for Natural Killer (NK) T Cells in the Suppression of Autoimmune Diseases

Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 5, Issue: 3
Page: 315-322
Authors: S. Miyake and T. Yamamura

Oral Tolerance in the Treatment of Rheumatoid Arthritis

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 1, Issue: 1
Page: 45-52
Authors: Eric A. Toussirot

Therapeutic Strategies in Autoimmune Diseases by Interfering with Leukocyte Endothelium Interaction

Journal: Current Pharmaceutical Design
Volume: 12, Issue: 29
Page: 3799-3806
Authors: Joachim Rychly and Barbara Nebe

Animal Models of Central Nervous System Immune-Mediated Diseases: Therapeutic Interventions with Bioactive Peptides and Mimetics

Journal: Current Medicinal Chemistry
Volume: 12, Issue: 13
Page: 1513-1519
Authors: Nikolaos Grigoriadis, Theodore Tselios, Spyros Deraos, Anastasios Orologas, George Deraos, John Matsoukas, Ioannis Mavromatis and Ioannis Milonas

Role of the Innate Immune System in Autoimmune Inflammatory Demyelination

Journal: Current Medicinal Chemistry
Volume: 15, Issue: 11
Page: 1105-1115
Authors: Kate O'Brien, Denise C. Fitzgerald, Karmeswaree Naiken, Kishore R. Alugupalli, A. M. Rostami and Bruno Gran

Etiopathogenesis, Classical Immunotherapy and Innovative Nanotherapeutics for Inflammatory Neurological Disorders

Journal: Current Nanoscience
Volume: 7, Issue: 1
Page: 2-20
Authors: Maria Jose Sa, Joana Guimaraes, Pedro Abreu, Amelia Mendes and Eliana B. Souto

Tolerance in the Absence of Autoantigen

Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 7, Issue: 3
Page: 203-210
Authors: D. W. Pascual, J. Ochoa-Reparaz, A. Rynda and X. Yang

Estrogens as Potential Therapeutic Agents in Multiple Sclerosis

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9, Issue: 2
Page: 87-94
Authors: Masaaki Niino, Makoto Hirotani, Toshiyuki Fukazawa, Seiji Kikuchi and Hidenao Sasaki

Histamine in Immune Regulation: Possible Roles in Autoimmune Demyelinating Disease of the Central Nervous System

Journal: Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume: 4, Issue: 6
Page: 637-643
Authors: Rosetta Pedotti and Lawrence Steinman

Novel Promising Therapeutic Agents in Multiple Sclerosis

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 1, Issue: 3
Page: 218-224
Authors: Abbas Mirshafiey

Gene Expression Studies in Multiple Sclerosis

Journal: Current Genomics
Volume: 8, Issue: 3
Page: 181-189
Authors: Lotti Tajouri, Francesca Fernandez and Lyn R. Griffiths

Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders

Journal: Current Pharmaceutical Design
Volume: 10, Issue: 2
Page: 155-161
Authors: Mae-Xhum Wong and Denise E. Jackson

Treatment of Central Nervous System Involvement Associated with Primary Sjogrens Syndrome

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 13
Page: 1270-1273
Authors: Salih Ozgocmen and Ali Gur

ATP-Binding Cassette Transporters in Inflammatory Brain Disease

Journal: Current Pharmaceutical Design
Volume: 17, Issue: 26
Page: 2803-2807
Authors: A. Chan, R. Gold and N. von Ahsen

Peroxisome Proliferator-Activated Receptor Agonists as Potential Therapeutic Agents in Multiple Sclerosis

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7, Issue: 11
Page: 1129-1135
Authors: Masaaki Niino

The Biology of Persistent Infection: Inflammation and Demyelination Following Murine Coronavirus Infection of the Central Nervous System

Journal: Current Immunology Reviews
Volume: 5, Issue: 4
Page: 267-276
Authors: Martin P. Hosking and Thomas E. Lane

TCR Peptide Vaccination in Multiple Sclerosis: Boosting a Deficient Natural Regulatory Network that may Involve TCR-Specific CD4+CD25+ Treg Cells

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4, Issue: 2
Page: 217-229
Authors: Arthur A. Vandenbark

Activation of Calpain and Caspase Pathways in Demyelination and Neurodegeneration in Animal Model of Multiple Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7, Issue: 3
Page: 313-320
Authors: Arabinda Das, M. Kelly Guyton, Jonathan T. Butler, Swapan K. Ray and Naren L. Banik

Modulators of Small- and Intermediate-Conductance Calcium-Activated Potassium Channels and their Therapeutic Indications

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 13
Page: 1437-1457
Authors: Heike Wulff, Aaron Kolski-Andreaco, Ananthakrishnan Sankaranarayanan, Jean-Marc Sabatier and Vikram Shakkottai

Multiple Sclerosis - A Coordinated Immune Attack Across the Blood Brain Barrier

Journal: Current Neurovascular Research
Volume: 1, Issue: 2
Page: 141-150
Authors: Bernhard Hemmer, Sabine Cepok, Dun Zhou and Norbert Sommer

The Blood-Central Nervous System Barriers Actively Control Immune Cell Entry into the Central Nervous System

Journal: Current Pharmaceutical Design
Volume: 14, Issue: 16
Page: 1555-1565
Authors: Britta Engelhardt

Experimental and Clinical Application of Plasmid DNA in the Field of Central Nervous Diseases

Journal: Current Gene Therapy
Volume: 11, Issue: 6
Page: 491-500
Authors: Munehisa Shimamura, Naoyuki Sato and Ryuichi Morishita

CD24 in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis: Targeting Redundancy for Immunotherapy?

Journal: Current Immunology Reviews
Volume: 1, Issue: 2
Page: 173-176
Authors: Yang Liu, Xue-Feng Bai, Qunmin Zhou, Ou Li and Pan Zheng

Leptin in Non-Autoimmune Inflammation

Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 8, Issue: 4
Page: 285-291
Authors: Chunlin Cai, Bevra H. Hahn, Giuseppe Matarese and Antonio La Cava

The Role of CD8+ T Cells in Multiple Sclerosis and its Animal Models

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4, Issue: 2
Page: 239-245
Authors: Joan Goverman, Antoine Perchellet and Eric S. Huseby

Mouse Models of Autoimmune Diseases

Journal: Current Drug Discovery Technologies
Volume: 6, Issue: 4
Page: 262-269
Authors: Andreia Marques and Susen Muller


Contribution of Spinal Cord Oligodendrocytes to Neuroinflammatory Diseases and Pain

Journal: Current Medicinal Chemistry
Volume: 25
Page: 1-28
Authors: Sergio M. Borghi , Victor Fattori , Miriam S. N. Hohmann and Waldiceu A. Verri*